Light Chain (AL) Amyloidosis

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Light Chain (AL) Amyloidosis.

Financial Assistance

2 programs

FINANCIAL LANDSCAPE SUMMARY

2

Total programs

2

Open now

1

Copay cards

1

Travel grants

Copay Assistance1

Darzalex

Janssen

OpenContact for detailsApply ↗

Travel Grants1

DARZALEX withMe Patient Assistance Program

Johnson & Johnson

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

2 FDA-approved

Darzalex

(daratumumab)Orphan drugstandard

Janssen Biotech, Inc.

CD38-directed Cytolytic Antibody [EPC]

12.1 Mechanism of Action CD38 is a transmembrane glycoprotein (48 kDa) expressed on the surface of hematopoietic cells, including clonal plasma cells ...

FDA label ↗

Darzalex Faspro

(DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT))Orphan drugstandard

Janssen Biotech, Inc.

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Light Chain (AL) Amyloidosis.
Search all trials →
Search clinical trials for Light Chain (AL) Amyloidosis

Recent News & Research

No recent news articles indexed yet for Light Chain (AL) Amyloidosis.
Search PubMed for Light Chain (AL) Amyloidosis

Browse all Light Chain (AL) Amyloidosis news →

Specialist Network

Top 6 by expertise

View all Light Chain (AL) Amyloidosis specialists →

Quick Actions